x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- Arnett, Donna KRemove Arnett, Donna K filter
- Ordovas, Jose MRemove Ordovas, Jose M filter
Publication Date
Please choose a date range between 2016 and 2018.
Author
- Hopkins, Paul N3
- Aslibekyan, Stella2
- Frazier-Wood, Alexis C2
- Abumrad, Nada A1
- Allum, Fiona1
- An, Ping1
- Bandinelli, Stefania1
- Borecki, Ingrid1
- Borecki, Ingrid B1
- Chen, Yii-Der I1
- Dave, Tushar1
- Deloukas, Panos1
- Duan, Yanan1
- Feitosa, Mary F1
- Ferrucci, Luigi1
- Fornage, Myriam1
- Geng, Xin1
- Grundberg, Elin1
- Guan, Weihua1
- Hedman, Åsa K1
- Hidalgo, Bertha1
- Hu, Frank B1
- Hu, Yao1
Keyword
- genetics3
- cholesterol1
- cholesterol/metabolism1
- cluster of differentiation 361
- deoxyribonucleic acid1
- dietary lipids1
- dyslipidemia1
- epidemiology1
- fatty acid/biosynthesis1
- fatty acid/desaturases1
- fatty acid/metabolism1
- high-density lipoprotein1
- lipoproteins1
- low density lipoprotein1
- low-density lipoprotein1
- monounsaturated fatty acid1
- postprandial lipemia1
- rare variant1
- single nucleotide polymorphism1
- triglyceride1
- whole-exome sequencing1
JLR Patient-Oriented and Epidemiological Research
3 Results
- Patient-Oriented and Epidemiological ResearchOpen Access
An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort
Journal of Lipid ResearchVol. 59Issue 4p722–729Published online: January 20, 2018- Xin Geng
- Marguerite R. Irvin
- Bertha Hidalgo
- Stella Aslibekyan
- Vinodh Srinivasasainagendra
- Ping An
- and others
Cited in Scopus: 5Our understanding of genetic influences on the response of lipids to specific interventions is limited. In this study, we sought to elucidate effects of rare genetic variants on lipid response to a high-fat meal challenge and fenofibrate (FFB) therapy in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) cohort using an exome-wide sequencing-based association study. Our results showed that the rare coding variants in ITGA7, SIPA1L2, and CEP72 are significantly associated with fasting LDL cholesterol response to FFB (P = 1.24E-07), triglyceride postprandial area under the increase (AUI) (P = 2.31E-06), and triglyceride postprandial AUI response to FFB (P = 1.88E-06), respectively. - Patient-Oriented and Epidemiological ResearchOpen Access
Discovery and fine-mapping of loci associated with MUFAs through trans-ethnic meta-analysis in Chinese and European populations
Journal of Lipid ResearchVol. 58Issue 5p974–981Published online: March 15, 2017- Yao Hu
- Toshiko Tanaka
- Jingwen Zhu
- Weihua Guan
- Jason H.Y. Wu
- Bruce M. Psaty
- and others
Cited in Scopus: 11MUFAs are unsaturated FAs with one double bond and are derived from endogenous synthesis and dietary intake. Accumulating evidence has suggested that plasma and erythrocyte MUFA levels are associated with cardiometabolic disorders, including CVD, T2D, and metabolic syndrome (MS). Previous genome-wide association studies (GWASs) have identified seven loci for plasma and erythrocyte palmitoleic and oleic acid levels in populations of European origin. To identify additional MUFA-associated loci and the potential functional variant at each locus, we performed ethnic-specific GWAS meta-analyses and trans-ethnic meta-analyses in more than 15,000 participants of Chinese and European ancestry. - Patient-Oriented and Epidemiological ResearchOpen Access
Higher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36
Journal of Lipid ResearchVol. 57Issue 12p2176–2184Published online: October 11, 2016- Latisha Love-Gregory
- Aldi T. Kraja
- Fiona Allum
- Stella Aslibekyan
- Åsa K. Hedman
- Yanan Duan
- and others
Cited in Scopus: 23Cluster of differentiation 36 (CD36) variants influence fasting lipids and risk of metabolic syndrome, but their impact on postprandial lipids, an independent risk factor for cardiovascular disease, is unclear. We determined the effects of SNPs within a ∼410 kb region encompassing CD36 and its proximal and distal promoters on chylomicron (CM) remnants and LDL particles at fasting and at 3.5 and 6 h following a high-fat meal (Genetics of Lipid Lowering Drugs and Diet Network study, n = 1,117). Five promoter variants associated with CMs, four with delayed TG clearance and five with LDL particle number.